Honey Does, Zarbee’s Makes Clear In Some Challenged Cough Product Claims, Not In Others
Executive Summary
National Advertising Division’s review of challenge by Maty’s Health Products finds Zarbee’s sufficiently identifies in some advertising that honey is the source of cough-soothing benefit but not in other ad claims. Zarbee’s says the review “was about the narrow issue of whether the ‘soothing cough’ claims were structured in a manner to convey the role of honey in providing the product’s cough benefits.”
You may also be interested in...
Maty's Ad Claims Comparing Natural Remedies To OTC Drugs Fail Review From Zarbees Challenge
Maty’s Healthy Products agrees to stop using claims for its children’s and adult cough and cold products after a Zarbees challenge reviewed by National Advertising Division, which found Maty’s made an apples-to-oranges comparison of its supplements to OTC drugs.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.